Biotech News

Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL

Amneal Pharmaceuticals (AMRX)Amneal PharmaceuticalsCompany update

AMRX (AMRX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is amrx.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Amneal Pharmaceuticals

Diversified Affordable Medicines Company Amneal Pharmaceuticals is a global biopharmaceutical company focused on expanding access to affordable and innovative medicines. Its portfolio includes approximately 300 complex generic, specialty, and biosimilar medicines, delivering more than 160 million prescriptions annually, primarily in the...

Recent company news

Stock data

Close
18.07 USD
Market cap
4.04B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States